Aims-To investigate the relation between sarcoidosis and lymphoma.
Sarcoidosis is a multisystem granulomatous disorder of uncertain origin and pathogenesis. Patients often present with bilateral mediastinal lymphadenopathy or lung lesions with characteristic radiological changes, or both. Involvement of other organs such as eye, skin and joints is also common. 1 The diagnosis of sarcoidosis is based on compatible clinical and radiological features, histological demonstration of non-caseating granulomas and exclusion of infectious or neoplastic diseases which may mimic sarcoidosis. 1 Although the aetiology of sarcoidosis is unknown, there is evidence that this disorder is associated with a dysfunction of the immune system, which may play a key pathogenetic role in this disease. Manifestations of immunological dysfunction include lymphopenia, an increase in CD4 + lymphocytes expressing activation markers in the bronchoalveolar lavage fluid, increased antigen expressing capacity and adhesion molecules on alveolar macrophages, and abnormal cytokine production. [2] [3] [4] [5] Here, we describe the clinical and histological features of five cases of lymphoma with a history of sarcoidosis and outline the possible mechanisms involved in the pathogenesis and coexistence of these diseases.
Methods
The hospital notes of five patients treated at The Royal Marsden Hospital, London, were reviewed and the information relevant to both diagnoses was recorded.
Biochemical features supporting the diagnosis of sarcoidosis were examined, including hypercalcaemia, lymphopenia, Kviem test, and findings in the bronchoalveolar lavage fluid. The original histological material on which the diagnosis of sarcoidosis and subsequently of lymphoma was made was also reviewed. Morphological examination of peripheral blood films and immunophenotyping by an indirect immunofluorescence technique were carried out in some cases.
Case reports CASE 1 In 1988 a 65 year old white man presented with haemoptysis and a chest x ray showed hilar and paratracheal lymphadenopathy; a lymph node biopsy specimen was reported as consistent with sarcoidosis.
Two years later, the patient developed peripheral lymphadenopathy with no other organomegaly, confirmed by computed tomography (CT) scan. A biopsy specimen of a supraclavicular node showed lymphoplasmacytic non-Hodgkin's lymphoma, low grade A according to the Working Formulation. Review of the original node histology showed a similar pattern to the second biopsy specimen. The patient was treated with six cycles of chlorambucil/prednisolone with no response, followed by five cycles of fludarabine with regression of lymphadenopathy and remains well 54 months after the diagnosis of non-Hodgkin's lymphoma.
Review of the original node histology showed a similar pattern to the second biopsy specimen. The normal architecture was diffusely replaced by sheets of a monomorphic lymphoid population ( fig 1) ; lymphoplasmacytic differentiation was prominent and epithelioid histiocytes were easily recognised. Therefore, a diagnosis of lymphoplasmacytic lymphoma was made with no evidence of sarcoidosis in any of the biopsy specimens. fig 4A) . In addition, there were numerous non-caseating granulomas ( fig 4B) . The findings were consistent with mantle cell lymphoma coexistent with sarcoidosis. The patient had further chemotherapy with no response and died of progressive disease. Epidemiological studies have confirmed that there is an increase in the incidence of lymphomas in patients with a history of sarcoidosis. In a series of 2544 patients with sarcoidosis, Brickner and Wilbek9 reported an incidence of lymphoid disorders about 11.5 higher than expected. However, the same authors, in a subsequent study based on 18% of the Danish population, estimated that the incidence was 5 5 higher than expected. The only other malignancy occurring with greater frequency in the same population was lung cancer (3.5/1).10
Results
The existence of this syndrome has been challenged after review of the records of the 48 cases initially identified." 12 However, in the literature reports continue to appear of lymphomas and acute myeloid leukaemias associated with sarcoidosis, suggesting an increased association between the two diseases.'1'6 Four of our patients (cases 2-5) represent what was described as "sarcoidosis-lymphoma" syndrome.'0 The three main features characteristic of the syndrome are: (1) the lymphoid malignancy occurs after a preceding history ofsarcoid; (2) the median age of onset of sarcoidosis is 10 years above that of unselected patients with sarcoid; (3) Hodgkin's disease occurs more frequently than other types of lymphoma. Brickner also suggested that the chronic type of sarcoidosis is more often associated with lymphoma, and that lymphopenia and treatment with steroids are predisposing factors for its development.'0 Although the number of cases described here is too small to draw conclusions, not all the features of our patients were reported by others. In agreement with Brickner's observations, three of four patients had been treated with steroids and two had progressive chronic disease. The time interval from the onset of sarcoidosis to the development of lymphoma was shorter in the cases with Hodgkin's and mantle cell lymphoma (18 and 36 months, respectively). This is in agreement with the previous observations that Hodgkin's and nonHodgkin's lymphoma occur earlier than chronic lymphocytic leukaemia and paraproteinaemias, and might reflect the different natural history of these lymphoid malignancies.'
In contrast to the published data, the median age of our patients at the time of onset of sarcoidosis was 37 years, not older than that expected for the unselected population with sarcoidosis. The lymphomas were of different subtypes: plasmacytoma, mantle cell and LGL leukaemia. To our knowledge, this is the first case of LGL leukaemia reported following sarcoidosis. In contrast to the lymphomas described in the literature and those included here, which are all of B cell origin, LGL leukaemia is a neoplastic disease of T cell origin. Reactive granuloma formation, although absent in this case, is a relatively frequent histological finding in the spleens from patients with LGL (Dr I A Lampert, unpublished observations), although the significance of this finding is unclear.
The causal relation between sarcoidosis and lymphoma is still a subject of speculation, but it is likely that there are several pathogenetic mechanisms involved. There is enough evidence to support the hypothesis that sarcoidosis is a predisposing factor for the development of a secondary lymphoid malignancy due to the disturbances of the immune system. In sarcoidosis there is a well documented increase in CD4 + T cells and a numerical reduction in CD8 + T cells within the affected tissues. The CD4 + cells express activation markers (interleukin-2 receptor, HLA-DR) and respond vigorously in vitro to mitogenic and antigenic stimulation and spontaneously release inter- 
